- AuthorisedTherapeutic use (Phase IV)
Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in addition to Minimum Inhibitory Concentration (MIC) to guide the treatment of periprosthetic joint infections; a prospective randomized clinical trial
This study looks at how best to treat infections around artificial hip or knee joints. It compares standard test results with a new test to see if combining them helps doctors choose better antibiotics and leads to fewer repeat infections or surgeries.
For: Periprosthetic hip joint infection Periprosthetic knee joint infectionSweden - AuthorisedTherapeutic exploratory (Phase II)
A randomised, prospective phase II study of pharmacokinetics and safety aspects of higher doses of rifampicin and pyrazinamide in a shortened treatment of mild-to-moderate tuberculosis compared with standard of care
This study is looking at new ways to treat mild to moderate tuberculosis (TB). Researchers are testing if higher doses of two existing medicines, rifampicin and pyrazinamide, can make treatment shorter and just as safe as current treatments. This could help people with TB get better faster.
For: TuberculosisSweden